There are few radiopharmaceuticals in clinical trials in the US (although there are several in use in Germany), so when a new one is announced, we take notice. Iodine-131-MIP-1095 (1-131-MIP-1095) has had a very limited clinical trial in Germany in 28 patients, and will now be tried in the US, starting at the Memorial Sloan-Kettering […]![]()
